Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical preparation treating bone lesions caused by malignant neoplasms

Pharmaceutical preparation treating bone lesions caused by malignant neoplasms

US Patent 11045487 · Granted Jun 29, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Drug combination treatments using bone-targeting therapeutics for bone and bone-2022
Drug combination treatments using bone-targeting therapeutics for bone and bone-2022
Ibandronate conjugates of nucleoside antimetabolites2022
Ibandronate conjugates of nucleoside antimetabolites2022
Stable dosage form of etidronate-cytarabine conjugate, and use thereof2022
Stable dosage form of etidronate-cytarabine conjugate, and use thereof2022
Stable dosage form of etidronate-cytarabine conjugate, and use thereof2022
Stable dosage form of etidronate-cytarabine conjugate, and use thereof2022
Stable dosage form of etidronate-cytarabine conjugate, and use thereof2022
Bone targeted therapeutics and methods of making and using the same2018
Bone targeted therapeutics and methods of making and using the same2018
Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside ph2016